Target Name: MINAR1
NCBI ID: G23251
Review Report on MINAR1 Target / Biomarker Content of Review Report on MINAR1 Target / Biomarker
MINAR1
Other Name(s): ubiquitination and mTOR signaling protein | KIAA1024 | Membrane integral NOTCH2-associated receptor 1 | MNAR1_HUMAN | Ubiquitination and mTOR signaling protein | UBTOR | major intrinsically disordered Notch2-associated receptor 1 | Major intrinsically disordered Notch2-binding receptor 1 | Membrane integral NOTCH2 associated receptor 1 | membrane integral NOTCH2 associated receptor 1

MINAR1: A versatile protein for drug targeting and biomarker development

MINAR1, a protein that belongs to the Mitochondrial Complex (MCO), is a key regulator of ubiquitination and mTOR signaling pathways. It is a 21-kDa protein that localizes to the mitochondrial inner mitochondrial membrane and plays a crucial role in the regulation of mitochondrial dynamics, energy metabolism, and cellular processes.

The discovery and characterization of MINAR1

The MCO is a protein complex that includes several proteins that are involved in the regulation of mitochondrial dynamics, including the protein MINAR1. MINAR1 was first identified as a protein that localizes to the mitochondrial inner mitochondrial membrane and is involved in the regulation of mitochondrial translation.

Subsequent studies have characterized the protein further and have revealed its various functions, including the regulation of mitochondrial dynamics, the maintenance of cellular homeostasis, and the regulation of cellular processes that are critical for the survival of cells.

MINAR1 as a drug target

MINAR1 has been identified as a potential drug target due to its various functions and its involvement in several cellular processes. The MCO is involved in the regulation of mitochondrial dynamics, which is critical for the proper functioning of the cell. Therefore, any drug that targets MINAR1 may have a wide range of potential therapeutic applications.

MINAR1 has also been shown to play a key role in the regulation of cellular homeostasis, which is critical for the survival of cells. Therefore, any drug that targets MINAR1 may also have implications for the treatment of various diseases that are characterized by disruptions in cellular homeostasis, such as cancer, neurodegenerative diseases, and metabolic disorders.

MINAR1 as a biomarker

MINAR1 has also been shown to serve as a potential biomarker for several diseases. Its involvement in the regulation of mitochondrial dynamics and cellular homeostasis makes it an attractive candidate for the diagnosis and prognosis of various diseases.

For example, MINAR1 has been shown to be downregulated in various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Therefore, the levels of MINAR1 may be an indicator of the severity of these diseases and may be used as a biomarker for their diagnosis and prognosis.

Conclusion

In conclusion, MINAR1 is a versatile protein that has a wide range of functions, including the regulation of mitochondrial dynamics, the maintenance of cellular homeostasis, and the regulation of cellular processes that are critical for the survival of cells. Its potential as a drug target and biomarker make it an attractive target for the development of new therapeutic approaches for the treatment of various diseases.

MINAR1 is a potential drug target that can be developed as a new therapeutic approach for the treatment of various diseases. Its characterization and its involvement in several cellular processes make it an attractive candidate for the development of new therapeutic approaches for the treatment of diseases that are characterized by disruptions in cellular homeostasis.

Protein Name: Membrane Integral NOTCH2 Associated Receptor 1

Functions: Intrinsically disordered protein which may negatively regulate mTOR signaling pathway by stabilizing the mTOR complex component DEPTOR (PubMed:30080879). Negatively regulates angiogenesis (PubMed:29329397). Negatively regulates cell growth (PubMed:29329397, PubMed:30080879). Negatively regulates neurite outgrowth in hippocampal neurons (By similarity)

The "MINAR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MINAR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MINAR2 | MINCR | MINDY1 | MINDY2 | MINDY2-DT | MINDY3 | MINDY4 | Minichromosome maintenance (MCM) 2-7 helicase complex | MINK1 | MINPP1 | MIOS | MIOX | MIP | MIPEP | MIPEPP3 | MIPOL1 | MIR1-1 | MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254